Knoll Capital Management as of Dec. 31, 2018
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 15 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 31.6 | $28M | 750k | 36.98 | |
| Corbus Pharmaceuticals Hldgs | 27.0 | $24M | 4.1M | 5.84 | |
| Abeona Therapeutics | 19.2 | $17M | 2.4M | 7.14 | |
| Krystal Biotech (KRYS) | 7.1 | $6.2M | 300k | 20.78 | |
| Aldeyra Therapeutics (ALDX) | 4.6 | $4.0M | 484k | 8.30 | |
| Electrocore | 2.8 | $2.5M | 397k | 6.26 | |
| Entera Bio (ENTX) | 1.6 | $1.5M | 476k | 3.05 | |
| Galmed Pharmaceuticals | 1.6 | $1.4M | 210k | 6.83 | |
| Anavex Life Sciences (AVXL) | 1.3 | $1.1M | 724k | 1.56 | |
| Eiger Biopharmaceuticals | 0.9 | $764k | 75k | 10.15 | |
| Soligenix | 0.8 | $721k | 838k | 0.86 | |
| Evoke Pharma | 0.8 | $682k | 275k | 2.48 | |
| Molecular Templates | 0.5 | $460k | 114k | 4.04 | |
| Chromadex Corp (CDXC) | 0.2 | $154k | 45k | 3.42 | |
| Lipocine | 0.1 | $65k | 50k | 1.30 |
